UB Paderborn / Katalog / Suche / in CDI

1 – 16 von 16

Sortiert nach

Patients' experience of accessing hepatitis C treatment through the Myanmar national hepatitis C treatment program: a qualitative evaluation

BMC health services research, 2024-01, Vol.24 (1), p.80-80, Article 80

2024

Volltextzugriff (PDF)

Reducing liver disease-related deaths in the Asia-Pacific: the important role of decentralised and non-specialist led hepatitis C treatment for cirrhotic patients

The Lancet regional health. Western Pacific, 2022-03, Vol.20, p.100359-100359, Article 100359

2022

Volltextzugriff (PDF)

Feasibility of decentralised, task-shifted hepatitis C testing and treatment services in urban Myanmar: implications for scale-up

BMJ open, 2022-05, Vol.12 (5), p.e059639-e059639

2022

Volltextzugriff (PDF)

Physician perspectives on the management of viral hepatitis and hepatocellular carcinoma in Myanmar

PloS one, 2017-08, Vol.12 (8), p.e0181603-e0181603

2017

Volltextzugriff (PDF)

Cost‐effectiveness of a decentralized, community‐based “one‐stop‐shop” hepatitis C testing and treatment program in Yangon, Myanmar

JGH open, 2023-11, Vol.7 (11), p.755-764

2023

Volltextzugriff (PDF)

Hepatitis C elimination in Myanmar: Modelling the impact, cost, cost-effectiveness and economic benefits

The Lancet regional health. Western Pacific, 2021-05, Vol.10, p.100129-100129, Article 100129

2021

Volltextzugriff (PDF)

AS037 - Community-based point-of-care hepatitis C testing and general practitioner initiated direct-acting antiviral therapy in Yangon, Myanmar (CT2 study)

Journal of hepatology, 2020-08, Vol.73, p.S31-S32

2020

Volltextzugriff (PDF)

Community-based point-of-care hepatitis C testing and general practitioner initiated direct-acting antiviral therapy in Yangon, Myanmar (CT2 study)

Journal of hepatology, 2020-08, Vol.73, p.S31-S32

2020

Volltextzugriff (PDF)

Decentralized, Community-Based Hepatitis C Point-of-Care Testing and Direct-Acting Antiviral Treatment for People Who Inject Drugs and the General Population in Myanmar: Protocol for a Feasibility Study

JMIR research protocols, 2020-07, Vol.9 (7), p.e16863-e16863

2020

Volltextzugriff (PDF)

Clinical trial of the intradermal administration of hepatitis B vaccine produced at the Department of Medical Research, Myanmar

Vaccine, 2002-02, Vol.20 (11), p.1649-1652

2002

Volltextzugriff (PDF)

A blood-based epigenetic test for early detection of hepatocellular carcinoma (HCC)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e15142-e15142

2014

Volltextzugriff (PDF)

DISSEMINATION OF REPRODUCTIVE HEALTH KNOWLEDGE BY QUESTIONS AND ANSWERS THROUGH TELEPHONE HOTLINE: A FEASIBILITY STUDY IN MYANMAR

Southeast Asian journal of tropical medicine and public health, 2011, Vol.42 (1), p.168-175

2011

Volltextzugriff (PDF)

Comparative study between molecular hybridization and electron microscopy for the detection of hepatitis E virus

Southeast Asian journal of tropical medicine and public health, 1993-09, Vol.24 (3), p.477-479

1993

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(16)

Sprache

Englisch
(16)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(12)
Life Sciences & Biomedicine
(11)
Hepatitis C
(6)
Humans
(6)
Infectious Diseases
(6)
Myanmar
(6)
Hepatitis
(5)
Infections
(5)
Adult
(4)
Health Care Sciences & Services
(4)
Hepatitis B
(4)
Hepatitis B Virus
(4)
Male
(4)
Public, Environmental & Occupational Health
(4)
Asia
(3)
Biological And Medical Sciences
(3)
Female
(3)
Gastroenterology
(3)
Gastroenterology & Hepatology
(3)
Hepatology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An expert review on the use of tenofovir alafenamide for the treatment of chronic hepatitis B virus infection in Asia

Patients' experience of accessing hepatitis C treatment through the Myanmar national hepatitis C treatment program: a qualitative evaluation

Reducing liver disease-related deaths in the Asia-Pacific: the important role of decentralised and non-specialist led hepatitis C treatment for cirrhotic patients

Feasibility of decentralised, task-shifted hepatitis C testing and treatment services in urban Myanmar: implications for scale-up

Physician perspectives on the management of viral hepatitis and hepatocellular carcinoma in Myanmar

Cost‐effectiveness of a decentralized, community‐based “one‐stop‐shop” hepatitis C testing and treatment program in Yangon, Myanmar

Hepatitis C elimination in Myanmar: Modelling the impact, cost, cost-effectiveness and economic benefits

AS037 - Community-based point-of-care hepatitis C testing and general practitioner initiated direct-acting antiviral therapy in Yangon, Myanmar (CT2 study)

Community-based point-of-care hepatitis C testing and general practitioner initiated direct-acting antiviral therapy in Yangon, Myanmar (CT2 study)

Decentralized, Community-Based Hepatitis C Point-of-Care Testing and Direct-Acting Antiviral Treatment for People Who Inject Drugs and the General Population in Myanmar: Protocol for a Feasibility Study

Asian consensus recommendations on optimizing the diagnosis and initiation of treatment of hepatitis B virus infection in resource‐limited settings

Clinical trial of the intradermal administration of hepatitis B vaccine produced at the Department of Medical Research, Myanmar

A blood-based epigenetic test for early detection of hepatocellular carcinoma (HCC)

DISSEMINATION OF REPRODUCTIVE HEALTH KNOWLEDGE BY QUESTIONS AND ANSWERS THROUGH TELEPHONE HOTLINE: A FEASIBILITY STUDY IN MYANMAR

Comparative study between molecular hybridization and electron microscopy for the detection of hepatitis E virus

Lipid profiles and determinants of total cholesterol and hypercholesterolaemia among 25–74 year-old urban and rural citizens of the Yangon Region, Myanmar: a cross-sectional study

Suchergebnisse filtern